Opko Health Inc. Stock Nyse
Equities
US68375N1037
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
||
- USD | - |
May. 07 | Earnings Flash (OPK) OPKO HEALTH Posts Q1 Revenue $173.7M, vs. Street Est of $183M | MT |
Mar. 28 | Laboratory Corp of America to Acquire BioReference's Diagnostics Business Select Assets | MT |
Financials (USD)
Sales 2024 * | 745M | Sales 2025 * | 796M | Capitalization | 906M |
---|---|---|---|---|---|
Net income 2024 * | -259M | Net income 2025 * | -185M | EV / Sales 2024 * | 1.22 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.14 x |
P/E ratio 2024 * |
-3.56
x | P/E ratio 2025 * |
-5.06
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 47.01% |
Latest transcript on Opko Health Inc.
Managers | Title | Age | Since |
---|---|---|---|
Phillip Frost
CEO | Chief Executive Officer | 87 | 07-03-26 |
Adam Logal
DFI | Director of Finance/CFO | 46 | 07-02-28 |
Elias Zerhouni
PSD | President | 72 | 22-05-08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Phillip Frost
CEO | Chief Executive Officer | 87 | 07-03-26 |
Roger Medel
BRD | Director/Board Member | 77 | 20-12-17 |
Director/Board Member | 68 | 07-12-31 |
1st Jan change | Capi. | |
---|---|---|
-16.27% | 8.36B | |
+50.91% | 3.84B | |
-34.71% | 2.64B | |
-9.28% | 2.48B | |
-9.89% | 2.33B | |
-3.77% | 1.98B | |
-17.29% | 1.6B | |
-36.54% | 1.27B | |
+5.98% | 1.11B |